Novo in the news

SAP Topples Novo to Become Europe's Biggest Listed Company

Read on: Bloomberg

Shortage of Novo's Wegovy and Ozempic is resolved, FDA website shows

Read on: CNBC News

Novo's Ozempic Notches Approval for Kidney Disease, Widening Use

Read on: Bloomberg

Novo Shares Soar on Promising Experimental Shot

Read on: Bloomberg

Defense, Novo and Nestle: 2024 Highs and Lows in European Stocks

Read on: Bloomberg

Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?

Read on: The Wall Street Journal

Novo's Ozempic Reduced Opioid Overdose Risk, Research Shows

Read on: Bloomberg

Novo CEO to blame drug middlemen

Read on: The Hill

Novo's Wegovy Puts a Higher Price on Heart Health in the US

Read on: Bloomberg

Norway's $1.7 Trillion Fund Trims Meta, Novo and ASML Stakes

Read on: Bloomberg

Lilly Gains in Obesity Race With Novo as Supplies Expand

Read on: Bloomberg

Novo's Supply Crunch, Germany's Pain: EMEA Earnings Week Ahead

Read on: Bloomberg

Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says

Read on: CNBC News

Discounts drive new home sales at SHKP's Novo Land in Tuen Mun as buyer sentiment improves

Read on: SCMP

Novo Blames US Health System After Sanders' Wegovy Criticism

Read on: Bloomberg

Novo Won't Meet Wegovy Demand in Short-Medium Term: CFO

Read on: Bloomberg

Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply

Read on: Axios

Why Obesity Drug Coverage Doesn't Matter (Yet) for Lilly and Novo

Read on: The Wall Street Journal

Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here's why, analyst says

Read on: CNBC News